Modulation of the humoral immune response by antibody-mediated antigen targeting to complement receptors and Fc receptors

Journal of Immunology

Volumn 162, Issue 6, 1999, Pages 3125-3130

  Baiu, Dana C ^a,b   Prechl, Jozsef ^a,c   Tchorbanov, Andrey ^a   Molina, Hector D ^d   Erdei, Anna ^c   Sulica, Andrei ^b   Capel, Peter J A ^a   Hazenbos, Wouter L W ^a,e  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Bucharest Center of Immunology   (Romania)

^c EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT RECEPTOR; FC RECEPTOR; IMMUNOGLOBULIN FC FRAGMENT; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ANTIGEN PRESENTATION; ARTICLE; DOWN REGULATION; GENETIC TRANSFECTION; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; LYMPHOMA CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; ANTIGENS; BINDING SITES, ANTIBODY; FEMALE; IMMUNOGLOBULIN G; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OVALBUMIN; PHOSPHORYLATION; RECEPTORS, COMPLEMENT 3B; RECEPTORS, COMPLEMENT 3D; RECEPTORS, FC; T-LYMPHOCYTES; TUMOR CELLS, CULTURED; TYROSINE;

EID: 0033559145     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Kinoshita, T., G. Thyphronitis, G. C. Tsokos, F. D. Finkelman, K. Hong, H. Sakai, and K. Inoue. 1990. Characterization of murine complement receptor type 2 and its immunological cross-reactivity with type 1 receptor. Int. Immunol. 2:651.
2. Molina, H., T. Kinoshita, K. Inoue, J.-C. Carel, and V. M. Holers. 1990. A molecular and immunochemical characterization of mouse CR2: evidence for a single gene model of mouse complement receptors 1 and 2. J. Immunol. 145: 2974.
3. Molina, H., W. Wong, T. Kinoshita, C. Brenner, S. Foley, and V. M. Holers. 1992. Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1. J. Exp. Med. 175:121.
4. Pramoonjago, P., J. Takeda, Y. U. Kim, K. Inoue, and T. Kinoshita. 1993. Ligand specificities of mouse complement receptors types 1 (CR1) and 2 (CR2) purified from spleen cells. Int. Immunol. 5:337.
5. Molina, H., T. Kinoshita, C. B. Webster, and V. M. Holers. 1994. Analysis of C3h/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2. J. Immunol. 153:789.
6. Carroll, M. C. 1998. The role of complement and complement receptors in induction and regulation of immunity. Annu. Rev. Immunol. 16:545.
7. Carter, R. H., M. O. Spycher, Y. C. Ng, R. Hoffman, and D. T. Fearon. 1988. Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J. Immunol. 141:457.
8. Mongini, P. K. A., M. A. Vilenski, P. Highet, and J. K. Inman. 1997. The affinity threshold for human B cell activation via the antigen receptor complex is reduced upon coligation of the antigen receptor with CD21 (CR2). J. Immunol. 159:3782.
9. Heyman, B., E. J. Wiersma, and T. Kinoshita. 1990. In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody. J. Exp. Med. 172:665.
10. Thyphronitis, G., T. Kinoshita, K. Inoue, J. E. Schweinle, G. C. Tsokos, E. S. Metcalf, F. D. Finkelman, and J. E. Balow. 1991. Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo. J. Immunol. 147:224.
11. Hebell, T., J. M. Ahearn, and D. T. Fearon. 1991. Suppression of the immune response by a soluble complement receptor of B lymphocytes. Science 254:102.
12. Molina, H., V. M. Holers, B. Li, Y.-F. Fang, S. Mariathasan, J. Goellner, J. Strauss-Schoenberger, R. W. Karr, and D. D. Chaplin. 1996. Markedly impaired humoral immune response in mice deficient in complement receptors I and 2. Proc. Natl. Acad. Sci. USA 93:3357.
13. Ahearn, J. A., M. B. Fischer, D. Croix, S. Goerg, M. Ma, J. Xia, X. Zhou, R. G. Howard, T. L. Rothstein, and M. C. Carroll. 1996. Disruption of the CR2 locus results in a reduction on B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4:251.
14. Dempsey, P. W., M. E. D. Allison, S. Akkaraju, C. C. Goodnow, D. T. Fearon. 1996. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271:348.
15. Fischer, M. B., M. Ma, S. Goerg, X. Zhou, J. Xia, O. Finco, H. Han, G. Kelsoe, R. G. Howard, T. L. Rothstein, et al. 1996. Regulation of the B cell response to T-dependent antigens by classical pathway complement. J. Immunol. 157:549.
16. Vivier, E., and M. Daëron. 1997. Immunoreceptor tyrosine-based inhibition motifs. Immunol. Today 18:286.
17. Van den Herik-Oudijk, I. E., P. J. A. Capel, T. van der Bruggen, and J. G. J. van de Winkel. 1995. Identification of signalling motifs within human FcγRIIa and FcγRIIb isoforms. Blood 85:2202.
18. Takai, T., M. Ono, M. Hikida, H. Ohmori, and J. V. Ravetch. 1996. Augmented humoral and anaphylactic responses in FcγRII-deficicnt mice. Nature 379:346.
19. Jones, B., J. P. Tite, and C. A. Janeway. 1986. Different phenotypic variants of the mouse B cell tumor A20/2J are selected by antigen- and mitogen-triggered cytotoxicity of L3T4-positive. 1A-restricted T cell clones. J. Immunol. 136:348.
20. Shimonkevitz, R., J. Kappler, P. Marrack, and H. Grey. 1983. Antigen recognition by H-2 restricted T cells. J. Exp. Med. 158:303.
21. Kinoshita, T., J. Takeda, K. Hong, H. Kozono, H. Sakai, and K. Inoue. 1988. Monoclonal antibodies to mouse complement receptor type 1 (CR1): their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative. J. Immunol. 140:3066.
22. Clark, M., C. Bindon, M. Dyer, P. Friend, G. Hale, S. Cobbold, R. Calne, and H. Waldmann. 1989. The improved lytic function and in vivo efficacy of monovalent CD3 antibodies. Eur. J. Immunol. 19:381.
23. Graziano, R. F., C. Somasundaram, and J. Goldstein. 1995. The production of bispecific antibodies. In Bispecific Antibodies. M. W. Fanger, ed. Springer-Verlag, New York, p. 1-26.
24. Kozono, Y., R. Abe, H. Kozono, R. G. Kelly, T. Azuma, and V. M. Holers. 1998. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells. J. Immunol. 160:1565.
25. Liu, Y.-J., G. D. Johnson, J. Gordon, and I. C. M. MacLennan. 1992. Germinal centers in T cell-dependent antibody responses. Immunol. Today 13:17.
26. Amigorena, S., D. Lankar, V. Briken, L. Gapin, M. Viguier, and C. Bonnerot. 1998. Type II and III receptors for immunoglobulin G (IgG) control the presentation of different T cell epitopes from single IgG-complexed antigens. J. Exp. Med. 4:505.
27. Heijnen, I. A. F. M., M. J. van Vugt, N. A. Fanger, R. F. Graziano, T. P. M. de Wit, F. M. A. Hofhuis, P. M. Guyre, P. J. A. Capel, J. S. Verbeek, and J. G. J. van de Winkel. 1996. Antigen targeting to myeloid-specific human FcγRI/CD64 triggers enhanced antibody responses in transgenic mice. J. Clin. Invest. 97:331.